EMERYVILLE, Calif., Feb. 22, 2021 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier...
Health and medicine
Protalix BioTherapeutics Completes Raise of Approximately $40 Million in Gross Proceeds
Anticipated PDUFA for PRX-102 in Fabry disease currently set for April 27, 2021 Company, with its Commercialization Partner, Chiesi, poised to commercialize PRX-102 Additional data and milestones expected throughout...